AIMC Topic: Cognitive Dysfunction

Clear Filters Showing 61 to 70 of 613 articles

Regional cortical thinning and area reduction are associated with cognitive impairment in hemodialysis patients.

Brain research bulletin
Magnetic resonance imaging (MRI) has shown that patients with end-stage renal disease have decreased gray matter volume and density. However, the cortical area and thickness in patients on hemodialysis are uncertain, and the relationship between pati...

Regional free-water diffusion is more strongly related to neuroinflammation than neurodegeneration.

Journal of neurology
INTRODUCTION: Recent research has suggested that neuroinflammation may be important in the pathogenesis of neurodegenerative diseases. Free-water diffusion (FWD) has been proposed as a non-invasive neuroimaging-based biomarker for neuroinflammation.

Exploring Factors Related to Social Isolation Among Older Adults in the Predementia Stage Using Ecological Momentary Assessments and Actigraphy: Machine Learning Approach.

Journal of medical Internet research
BACKGROUND: As the global population ages, the economic burden of dementia continues to rise. Social isolation-which includes limited social interaction and feelings of loneliness-negatively affects cognitive function and is a significant risk factor...

The Rapid Online Cognitive Assessment for the Detection of Neurocognitive Disorder: Open-Label Study.

Journal of medical Internet research
BACKGROUND: The rising prevalence of dementia necessitates a scalable solution to cognitive screening. Paper-based cognitive screening examinations are well-validated but minimally scalable. If a digital cognitive screening examination could replicat...

Digital Therapeutics for Cognitive Impairment: Exploring Innovations, Challenges, and Future Prospects.

Journal of medical Internet research
Recent advancements in cognitive neuroscience and digital technology have significantly accelerated the adoption of digital therapeutics for cognitive impairment. This viewpoint explores the innovative applications of digital therapeutics in the asse...

An ensemble-based 3D residual network for the classification of Alzheimer's disease.

PloS one
Alzheimer's disease (AD) is a common type of dementia, with mild cognitive impairment (MCI) being a key precursor. Early MCI diagnosis is crucial for slowing AD progression, but distinguishing MCI from normal controls (NC) is challenging due to subtl...

A multi-site randomized clinical trial of socially assistive robots on engaging older adults with cognitive impairment residing in long-term care settings: A protocol paper.

Contemporary clinical trials
Apathy is common in persons with dementias, especially those in long-term care facilities (LTCs). Few pharmacologic options exist; a major strategy is to foster engagement in social, physical, and cognitive activities, but requires extensive personne...

Machine learning-based prediction model for cognitive impairment risk in patients with chronic kidney disease.

PloS one
BACKGROUND: The high prevalence of cognitive impairment (CI) in Chronic kidney disease (CKD) patients impacts their quality of life and prognosis, yet risk prediction models for CI in this population remain underexplored.

Dynamically weighted graph neural network for detection of early mild cognitive impairment.

PloS one
Alzheimer's disease (AD) is a prevalent neurodegenerative disease that primarily affects the elderly population. The early detection of mild cognitive impairment (MCI) holds significant clinical importance for prompt intervention and treatment of AD....